Inactivation of infectious pathogens in labile blood components: meeting the challenge
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 8 (3) , 138-145
- https://doi.org/10.1016/s1246-7820(01)00117-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection of red cells but not of vesicular stomatitis virus with a water-soluble analogue of vitamin ETransfusion, 1995
- A prospective study of symptomatic bacteremia following platelet transfusion and of its managementTransfusion, 1994
- The Role of the Plasma from Platelet Concentrates in Transfusion ReactionsNew England Journal of Medicine, 1994
- Transfusion‐transmitted babesiosis: a case report from a new endemic areaTransfusion, 1991
- Inactivation of viruses in blood with aluminum phthalocyanine derivativesTransfusion, 1991
- Blood Product-Associated Bacterial SepsisTransfusion Medicine Reviews, 1991
- Reports of 355 transfusion‐associated deaths: 1976 through 1985Transfusion, 1990
- PHOTOCHEMICAL DECONTAMINATION OF BLOOD COMPONENTS CONTAINING HEPATITIS B AND NON-A, NON-B VIRUSThe Lancet, 1988
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985